{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:28:57Z","timestamp":1793363337860,"version":"4.5.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10495-025-02148-3","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:24:28Z","timestamp":1753298668000},"page":"2019-2041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise"],"prefix":"10.1007","volume":"30","author":[{"given":"Nasreen","family":"Sulthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Ballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita Joshi","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumna","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Sadique","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"2148_CR1","doi-asserted-by":"crossref","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23","DOI":"10.3390\/ijms23031851"},{"key":"2148_CR2","doi-asserted-by":"crossref","unstructured":"Gonzales MM, Garbarino VR, Pollet E, Palavicini JP, Kellogg DL Jr, Kraig E et al (2022) Biological aging processes underlying cognitive decline and neurodegenerative disease. J Clin Investig 132","DOI":"10.1172\/JCI158453"},{"key":"2148_CR3","doi-asserted-by":"publisher","first-page":"149776","DOI":"10.1016\/j.brainres.2025.149776","volume":"1864","author":"G Khan","year":"2025","unstructured":"Khan G, Hussain MS, Khan Y, Fatima R, Ahmad S, Sultana A et al (2025) Ferroptosis and its contribution to cognitive impairment in alzheimer\u2019s disease: mechanisms and therapeutic potential. Brain Res 1864:149776","journal-title":"Brain Res"},{"key":"2148_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I (2023) Hallmarks of neurodegenerative diseases. Cell 186:693\u2013714","journal-title":"Cell"},{"key":"2148_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41583-024-00806-0","volume":"25","author":"M Kampmann","year":"2024","unstructured":"Kampmann M (2024) Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases. Nat Rev Neurosci 25:351\u2013371","journal-title":"Nat Rev Neurosci"},{"key":"2148_CR6","doi-asserted-by":"publisher","first-page":"e00105","DOI":"10.1002\/cbdv.202500105","volume":"22","author":"MR Islam","year":"2025","unstructured":"Islam MR, Rauf A, Rahaman MS, Al-Imran MIK, Fakir MNH, Akter S et al (2025) Clinical and mechanistic exploration of ellagic acid in neurodegenerative diseases: targeted neuroprotection through cellular and molecular mechanisms. Chem Biodivers 22:e00105","journal-title":"Chem Biodivers"},{"key":"2148_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.14283\/jpad.2024.21","volume":"11","author":"Z Li","year":"2024","unstructured":"Li Z, Yang N, He L, Wang J, Yang Y, Ping F et al (2024) Global burden of dementia death from 1990 to 2019, with projections to 2050: an analysis of 2019 global burden of disease study. J Prev Alzheimer\u2019s Disease 11:1013\u20131021","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"2148_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s42003-024-06386-0","volume":"7","author":"T Odawara","year":"2024","unstructured":"Odawara T, Yamauchi S, Ichijo H (2024) Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging. Commun Biology 7:691","journal-title":"Commun Biology"},{"key":"2148_CR9","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/j.vph.2022.107088","volume":"145","author":"H Giri","year":"2022","unstructured":"Giri H, Srivastava AK, Naik UP (2022) Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability. Vascul Pharmacol 145:107088","journal-title":"Vascul Pharmacol"},{"key":"2148_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1515\/med-2022-0596","volume":"17","author":"LO Xinastle-Castillo","year":"2022","unstructured":"Xinastle-Castillo LO, Landa A (2022) Physiological and modulatory role of thioredoxins in the cellular function. Open Med (Warsaw Poland) 17:2021\u20132035","journal-title":"Open Med (Warsaw Poland)"},{"key":"2148_CR11","doi-asserted-by":"crossref","unstructured":"Obsilova V, Honzejkova K, Obsil T (2021) Structural insights support targeting ASK1 kinase for therapeutic interventions. Int J Mol Sci 22","DOI":"10.3390\/ijms222413395"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"1210962","DOI":"10.3389\/fnmol.2023.1210962","volume":"16","author":"B Garc\u00eda-Hern\u00e1ndez","year":"2023","unstructured":"Garc\u00eda-Hern\u00e1ndez B, Mor\u00e1n J (2023) Txnip expression promotes JNK-mediated neuronal death in response to reactive oxygen species. Front Mol Neurosci 16:1210962","journal-title":"Front Mol Neurosci"},{"key":"2148_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/neup.12978","volume":"45","author":"E Seki","year":"2025","unstructured":"Seki E, Guo X, Namekata K, Komori T, Hayashi H, Arai N et al (2025) ASK1 activation in glial cells in post-mortem multiple sclerosis tissue. Neuropathol Offic J Japanese Soc Neuropathol 45:20\u201329","journal-title":"Neuropathol Offic J Japanese Soc Neuropathol"},{"key":"2148_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2020.12.081","volume":"548","author":"J Sun","year":"2021","unstructured":"Sun J, Qin X, Zhang X, Wang Q, Zhang W, Wang M (2021) FBXW11 deletion alleviates alzheimer\u2019s disease by reducing neuroinflammation and amyloid-\u03b2 plaque formation via repression of ASK1 signaling. Biochem Biophys Res Commun 548:104\u2013111","journal-title":"Biochem Biophys Res Commun"},{"key":"2148_CR15","doi-asserted-by":"crossref","unstructured":"Guo X, Kimura A, Namekata K, Harada C, Arai N, Takeda K et al (2022) ASK1 signaling regulates phase-specific glial interactions during neuroinflammation. Proc Natl Acad Sci USA 119","DOI":"10.1073\/pnas.2103812119"},{"key":"2148_CR16","doi-asserted-by":"publisher","first-page":"147310","DOI":"10.1016\/j.brainres.2021.147310","volume":"1757","author":"J Liu","year":"2021","unstructured":"Liu J, Hu H, Wu B (2021) RIPK1 inhibitor ameliorates the MPP(+)\/MPTP-induced parkinson\u2019s disease through the ASK1\/JNK signalling pathway. Brain Res 1757:147310","journal-title":"Brain Res"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"987293","DOI":"10.3389\/fphar.2022.987293","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang L, Yang Y, Cai C, Wang X, Deng L et al (2022) DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress. Front Pharmacol 13:987293","journal-title":"Front Pharmacol"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4103\/NRR.NRR-D-24-00225","volume":"20","author":"X Guo","year":"2025","unstructured":"Guo X, Harada C, Harada T (2025) Asking one mechanism in glial cells during neuroinflammation. Neural Regeneration Res 20:1077\u20131078","journal-title":"Neural Regeneration Res"},{"key":"2148_CR19","doi-asserted-by":"publisher","first-page":"117214","DOI":"10.1016\/j.biopha.2024.117214","volume":"178","author":"B Wang","year":"2024","unstructured":"Wang B, Ma Y, Zhang Y, Yin X (2024) Therapeutic potential of ASK1 activators in cancer treatment: current insights and future directions. Biomed Pharmacother 178:117214","journal-title":"Biomed Pharmacother"},{"key":"2148_CR20","doi-asserted-by":"publisher","first-page":"15402","DOI":"10.1021\/acs.jmedchem.1c01458","volume":"64","author":"JH Jones","year":"2021","unstructured":"Jones JH, Xin Z, Himmelbauer M, Dechantsreiter M, Enyedy I, Hedde J et al (2021) Discovery of potent, selective, and brain-Penetrant apoptosis Signal-Regulating kinase 1 (ASK1) inhibitors that modulate brain inflammation in vivo. J Med Chem 64:15402\u201315419","journal-title":"J Med Chem"},{"key":"2148_CR21","first-page":"90","volume-title":"Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways","author":"H Ichijo","year":"1997","unstructured":"Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T et al (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways, vol 275. Science, New York, NY, pp 90\u201394"},{"key":"2148_CR22","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","volume":"17","author":"M Saitoh","year":"1998","unstructured":"Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y et al (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596\u20132606","journal-title":"EMBO J"},{"key":"2148_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/15230860260196218","volume":"4","author":"A Matsuzawa","year":"2002","unstructured":"Matsuzawa A, Nishitoh H, Tobiume K, Takeda K, Ichijo H (2002) Physiological roles of ASK1-mediated signal transduction in oxidative stress- and Endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid Redox Signal 4:415\u2013425","journal-title":"Antioxid Redox Signal"},{"key":"2148_CR24","doi-asserted-by":"publisher","first-page":"26576","DOI":"10.1074\/jbc.M003412200","volume":"275","author":"T Hatai","year":"2000","unstructured":"Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K et al (2000) Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 275:26576\u201326581","journal-title":"J Biol Chem"},{"key":"2148_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1097-2765(00)80283-X","volume":"2","author":"H Nishitoh","year":"1998","unstructured":"Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M et al (1998) ASK1 is essential for JNK\/SAPK activation by TRAF2. Mol Cell 2:389\u2013395","journal-title":"Mol Cell"},{"key":"2148_CR26","doi-asserted-by":"crossref","unstructured":"Honzejkova K, Kosek D, Obsilova V, Obsil T (2024) The cryo-EM structure of ASK1 reveals an asymmetric architecture allosterically modulated by TRX1. eLife 13","DOI":"10.7554\/eLife.95199.2"},{"key":"2148_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/embo-reports\/kve046","volume":"2","author":"K Tobiume","year":"2001","unstructured":"Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K et al (2001) ASK1 is required for sustained activations of JNK\/p38 MAP kinases and apoptosis. EMBO Rep 2:222\u2013228","journal-title":"EMBO Rep"},{"key":"2148_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2183\/pjab.88.434","volume":"88","author":"R Hayakawa","year":"2012","unstructured":"Hayakawa R, Hayakawa T, Takeda K, Ichijo H (2012) Therapeutic targets in the ASK1-dependent stress signaling pathways. Proc Japan Acad Ser B Phys Biol Sci 88:434\u2013453","journal-title":"Proc Japan Acad Ser B Phys Biol Sci"},{"key":"2148_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-55330-6_14","volume":"982","author":"C Chen","year":"2017","unstructured":"Chen C, Chen H, Zhou HJ, Ji W, Min W (2017) Mechanistic role of thioredoxin 2 in heart failure. Adv Exp Med Biol 982:265\u2013276","journal-title":"Adv Exp Med Biol"},{"key":"2148_CR30","doi-asserted-by":"publisher","first-page":"101400","DOI":"10.1016\/j.redox.2019.101400","volume":"29","author":"N Shu","year":"2020","unstructured":"Shu N, H\u00e4gglund P, Cai H, Hawkins CL, Davies MJ (2020) Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes Inhibition of its catalytic activity and activation of the ASK1\/p38-MAPK signalling pathway. Redox Biol 29:101400","journal-title":"Redox Biol"},{"key":"2148_CR31","doi-asserted-by":"publisher","first-page":"E2096","DOI":"10.1073\/pnas.1620813114","volume":"114","author":"JF Weijman","year":"2017","unstructured":"Weijman JF, Kumar A, Jamieson SA, King CM, Caradoc-Davies TT, Ledgerwood EC et al (2017) Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1. Proc Natl Acad Sci USA 114:E2096\u2013e105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2148_CR32","doi-asserted-by":"publisher","first-page":"439587","DOI":"10.1155\/2012\/439587","volume":"2012","author":"M Soga","year":"2012","unstructured":"Soga M, Matsuzawa A, Ichijo H (2012) Oxidative Stress-Induced diseases via the ASK1 signaling pathway. Int J Cell Biology 2012:439587","journal-title":"Int J Cell Biology"},{"key":"2148_CR33","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1093\/emboj\/20.21.6028","volume":"20","author":"K Morita","year":"2001","unstructured":"Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H et al (2001) Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20:6028\u20136036","journal-title":"EMBO J"},{"key":"2148_CR34","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1172\/JCI200317790","volume":"111","author":"R Zhang","year":"2003","unstructured":"Zhang R, He X, Liu W, Lu M, Hsieh JT, Min W (2003) AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J Clin Investig 111:1933\u20131943","journal-title":"J Clin Investig"},{"key":"2148_CR35","doi-asserted-by":"crossref","unstructured":"Wang T, Pang L, He M, Wang Z (2023) Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1. Eur J Med Chem.:115889","DOI":"10.1016\/j.ejmech.2023.115889"},{"key":"2148_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.pmch.2020.02.001","volume":"59","author":"R Brys","year":"2020","unstructured":"Brys R, Gibson K, Poljak T, Van Der Plas S, Amantini D (2020) Discovery and development of ASK1 inhibitors. Prog Med Chem 59:101\u2013179","journal-title":"Prog Med Chem"},{"key":"2148_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jbior.2017.10.002","volume":"66","author":"T Obsil","year":"2017","unstructured":"Obsil T, Obsilova V (2017) Structural aspects of protein kinase ASK1 regulation. Adv Biol Regul 66:31\u201336","journal-title":"Adv Biol Regul"},{"key":"2148_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.str.2007.08.011","volume":"15","author":"G Bunkoczi","year":"2007","unstructured":"Bunkoczi G, Salah E, Filippakopoulos P, Fedorov O, M\u00fcller S, Sobott F et al (2007) Structural and functional characterization of the human protein kinase ASK1. Structure 15:1215\u20131226","journal-title":"Structure"},{"key":"2148_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcp.10080","volume":"191","author":"K Tobiume","year":"2002","unstructured":"Tobiume K, Saitoh M, Ichijo H (2002) Activation of apoptosis signal-regulating kinase 1 by the stress\u2010induced activating phosphorylation of pre\u2010formed oligomer. J Cell Physiol 191:95\u2013104","journal-title":"J Cell Physiol"},{"key":"2148_CR40","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.celrep.2017.11.007","volume":"21","author":"Y Hirata","year":"2017","unstructured":"Hirata Y, Katagiri K, Nagaoka K, Morishita T, Kudoh Y, Hatta T et al (2017) TRIM48 promotes ASK1 activation and cell death through ubiquitination-dependent degradation of the ASK1-negative regulator PRMT1. Cell Rep 21:2447\u20132457","journal-title":"Cell Rep"},{"key":"2148_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1021\/acs.biochem.7b01083","volume":"57","author":"DN Kekulandara","year":"2018","unstructured":"Kekulandara DN, Nagi S, Seo H, Chow CS, Ahn Y-H (2018) Redox-Inactive peptide disrupting Trx1\u2013Ask1 interaction for selective activation of stress signaling. Biochemistry 57:772\u2013780","journal-title":"Biochemistry"},{"key":"2148_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jbior.2017.05.004","volume":"66","author":"T Nishida","year":"2017","unstructured":"Nishida T, Hattori K, Watanabe K (2017) The regulatory and signaling mechanisms of the ASK family. Adv Biol Regul 66:2\u201322","journal-title":"Adv Biol Regul"},{"key":"2148_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1517\/14728222.2014.896903","volume":"18","author":"Y Kawarazaki","year":"2014","unstructured":"Kawarazaki Y, Ichijo H, Naguro I (2014) Apoptosis signal-regulating kinase 1 as a therapeutic target. Expert Opin Ther Targets 18:651\u2013664","journal-title":"Expert Opin Ther Targets"},{"key":"2148_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-13-221","volume":"13","author":"X Cheng","year":"2014","unstructured":"Cheng X, Holenya P, Can S, Alborzinia H, Rubbiani R, Ott I et al (2014) A TrxR inhibiting gold (I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells. Mol Cancer 13:1\u201315","journal-title":"Mol Cancer"},{"key":"2148_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","volume":"7","author":"H Pelicano","year":"2004","unstructured":"Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 7:97\u2013110","journal-title":"Drug Resist Updates"},{"key":"2148_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.11644","volume":"109","author":"J Fang","year":"2004","unstructured":"Fang J, Sawa T, Akaike T, Greish K, Maeda H (2004) Enhancement of chemotherapeutic response of tumor cells by a Heme Oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 109:1\u20138","journal-title":"Int J Cancer"},{"key":"2148_CR47","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1091\/mbc.e13-10-0590","volume":"25","author":"M Ishaq","year":"2014","unstructured":"Ishaq M, Kumar S, Varinli H, Han ZJ, Rider AE, Evans MD et al (2014) Atmospheric gas plasma\u2013induced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosis. Mol Biol Cell 25:1523\u20131531","journal-title":"Mol Biol Cell"},{"key":"2148_CR48","doi-asserted-by":"publisher","first-page":"15754","DOI":"10.3390\/ijms150915754","volume":"15","author":"T Liang","year":"2014","unstructured":"Liang T, Zhang X, Xue W, Zhao S, Zhang X, Pei J (2014) Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway. Int J Mol Sci 15:15754\u201315765","journal-title":"Int J Mol Sci"},{"key":"2148_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00109-022-02188-1","volume":"100","author":"JM Ogier","year":"2022","unstructured":"Ogier JM, Gao Y, Dunne EM, Wilson MA, Ranganathan SC, Tesch GH et al (2022) ASK1 is a novel molecular target for preventing aminoglycoside-induced hair cell death. J Mol Med 100:797\u2013813","journal-title":"J Mol Med"},{"key":"2148_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-020-01878-y","volume":"98","author":"JM Ogier","year":"2020","unstructured":"Ogier JM, Nayagam BA, Lockhart PJ (2020) ASK1 inhibition: a therapeutic strategy with multi-system benefits. J Mol Med 98:335\u2013348","journal-title":"J Mol Med"},{"key":"2148_CR51","doi-asserted-by":"publisher","first-page":"107167","DOI":"10.1016\/j.bioorg.2024.107167","volume":"144","author":"L Pang","year":"2024","unstructured":"Pang L, Wang T, Huang J, Wang J, Niu X, Fan H et al (2024) Discovery of a quinoline-containing compound JT21-25 as a potent and selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1). Bioorg Chem 144:107167","journal-title":"Bioorg Chem"},{"key":"2148_CR52","doi-asserted-by":"publisher","first-page":"112277","DOI":"10.1016\/j.ejmech.2020.112277","volume":"195","author":"S Zhang","year":"2020","unstructured":"Zhang S, Huang C, Lyu X, Wang P, Zang Y, Wang Z et al (2020) Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1). Eur J Med Chem 195:112277","journal-title":"Eur J Med Chem"},{"key":"2148_CR53","doi-asserted-by":"publisher","first-page":"37033","DOI":"10.1074\/jbc.M506771200","volume":"280","author":"T Noguchi","year":"2005","unstructured":"Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J et al (2005) Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J Biol Chem 280:37033\u201337040","journal-title":"J Biol Chem"},{"key":"2148_CR54","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.molcel.2009.10.016","volume":"36","author":"H Nagai","year":"2009","unstructured":"Nagai H, Noguchi T, Homma K, Katagiri K, Takeda K, Matsuzawa A et al (2009) Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death. Mol Cell 36:805\u2013818","journal-title":"Mol Cell"},{"key":"2148_CR55","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1074\/jbc.M311129200","volume":"279","author":"EH Goldman","year":"2004","unstructured":"Goldman EH, Chen L, Fu H (2004) Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at Serine 967 and 14-3-3 dissociation. J Biol Chem 279:10442\u201310449","journal-title":"J Biol Chem"},{"key":"2148_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-7-9","volume":"7","author":"K Hattori","year":"2009","unstructured":"Hattori K, Naguro I, Runchel C, Ichijo H (2009) The roles of ASK family proteins in stress responses and diseases. Cell Communication Signal 7:1\u201310","journal-title":"Cell Communication Signal"},{"key":"2148_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12033-007-0053-x","volume":"37","author":"T Fujisawa","year":"2007","unstructured":"Fujisawa T, Takeda K, Ichijo H (2007) ASK family proteins in stress response and disease. Mol Biotechnol 37:13\u201318","journal-title":"Mol Biotechnol"},{"key":"2148_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ni1200","volume":"6","author":"A Matsuzawa","year":"2005","unstructured":"Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al (2005) ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6:587\u2013592","journal-title":"Nat Immunol"},{"key":"2148_CR59","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1101\/gad.992302","volume":"16","author":"H Nishitoh","year":"2002","unstructured":"Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K et al (2002) ASK1 is essential for Endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16:1345\u20131355","journal-title":"Genes Dev"},{"key":"2148_CR60","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3390\/ijms15022119","volume":"15","author":"J Song","year":"2014","unstructured":"Song J, Park KA, Lee WT, Lee JE (2014) Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for alzheimer\u2019s disease. Int J Mol Sci 15:2119\u20132129","journal-title":"Int J Mol Sci"},{"key":"2148_CR61","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCRESAHA.107.168153","volume":"102","author":"W Min","year":"2008","unstructured":"Min W, Lin Y, Tang S, Yu L, Zhang H, Wan T et al (2008) AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor\u2013induced ASK1-JNK activation. Circul Res 102:840\u2013848","journal-title":"Circul Res"},{"key":"2148_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrgastro.2017.42","volume":"14","author":"S Schuster","year":"2017","unstructured":"Schuster S, Feldstein AE (2017) Novel therapeutic strategies targeting ASK1 in NASH. Nat Reviews Gastroenterol Hepatol 14:329\u2013330","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2148_CR63","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1038\/ncomms9350","volume":"6","author":"T Tomida","year":"2015","unstructured":"Tomida T, Takekawa M, Saito H (2015) Oscillation of p38 activity controls efficient pro-inflammatory gene expression. Nat Commun 6:8350","journal-title":"Nat Commun"},{"key":"2148_CR64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jbior.2017.10.004","volume":"66","author":"T Fujisawa","year":"2017","unstructured":"Fujisawa T (2017) Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors. Adv Biol Regul 66:85\u201390","journal-title":"Adv Biol Regul"},{"key":"2148_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcell.2016.00031","volume":"4","author":"A Esc\u00f3s","year":"2016","unstructured":"Esc\u00f3s A, Risco A, Alsina-Beauchamp D, Cuenda A (2016) p38\u03b3 and p38\u03b4 mitogen activated protein kinases (MAPKs), new stars in the MAPK galaxy. Front Cell Dev Biology 4:31","journal-title":"Front Cell Dev Biology"},{"key":"2148_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jbior.2017.10.007","volume":"66","author":"A Matsuzawa","year":"2017","unstructured":"Matsuzawa A (2017) Physiological roles of ASK family members in innate immunity and their involvement in pathogenesis of immune diseases. Adv Biol Regul 66:46\u201353","journal-title":"Adv Biol Regul"},{"key":"2148_CR67","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Lim\u00f3n A, Joaquin M, Caballero M, Posas F, de Nadal E (2020) The p38 pathway: from biology to Cancer therapy. Int J Mol Sci 21","DOI":"10.3390\/ijms21061913"},{"key":"2148_CR68","doi-asserted-by":"publisher","first-page":"129332","DOI":"10.1016\/j.ijbiomac.2024.129332","volume":"260","author":"H Yang","year":"2024","unstructured":"Yang H, Zhou H, Fu M, Xu H, Huang H, Zhong M et al (2024) TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Macromol 260:129332","journal-title":"Int J Biol Macromol"},{"key":"2148_CR69","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-16-0155","volume":"76","author":"T Muranen","year":"2016","unstructured":"Muranen T, Selfors LM, Hwang J, Gallegos LL, Coloff JL, Thoreen CC et al (2016) ERK and p38 MAPK activities determine sensitivity to PI3K\/mTOR Inhibition via regulation of MYC and YAP. Cancer Res 76:7168\u20137180","journal-title":"Cancer Res"},{"key":"2148_CR70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR (2021) Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol 22:346\u2013366","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2148_CR71","doi-asserted-by":"crossref","unstructured":"Dolado I, Nebreda AR (2008) Regulation of tumorigenesis by p38 \u03b1 MAP kinase. Stress-activated Protein Kinases.:99\u2013128","DOI":"10.1007\/4735_2007_0245"},{"key":"2148_CR72","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ccell.2015.09.009","volume":"28","author":"IG Cannell","year":"2015","unstructured":"Cannell IG, Merrick KA, Morandell S, Zhu C-Q, Braun CJ, Grant RA et al (2015) A pleiotropic RNA-binding protein controls distinct cell cycle checkpoints to drive resistance of p53-defective tumors to chemotherapy. Cancer Cell 28:623\u2013637","journal-title":"Cancer Cell"},{"key":"2148_CR73","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.4049\/jimmunol.1700727","volume":"200","author":"C G\u00f6pfert","year":"2018","unstructured":"G\u00f6pfert C, Andreas N, Weber F, H\u00e4fner N, Yakovleva T, Gaestel M et al (2018) The p38-MK2\/3 module is critical for IL-33-Induced signaling and cytokine production in dendritic cells. J Immunol (Baltimore Md: 1950) 200:1198\u20131206","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"2148_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jbior.2017.05.003","volume":"66","author":"H Ryuno","year":"2017","unstructured":"Ryuno H, Naguro I, Kamiyama M (2017) ASK family and cancer. Adv Biol Regul 66:72\u201384","journal-title":"Adv Biol Regul"},{"key":"2148_CR75","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jdermsci.2018.01.015","volume":"90","author":"N Kusumaningrum","year":"2018","unstructured":"Kusumaningrum N, Lee DH, Yoon HS, Kim YK, Park CH, Chung JH (2018) Gasdermin C is induced by ultraviolet light and contributes to MMP-1 expression via activation of ERK and JNK pathways. J Dermatol Sci 90:180\u2013189","journal-title":"J Dermatol Sci"},{"key":"2148_CR76","doi-asserted-by":"crossref","unstructured":"Hammouda MB, Ford AE, Liu Y, Zhang JY (2020) The JNK signaling pathway in inflammatory skin disorders and Cancer. Cells 9","DOI":"10.3390\/cells9040857"},{"key":"2148_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1164\/ajrccm.163.1.2005069","volume":"163","author":"S Hashimoto","year":"2001","unstructured":"Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S, Horie T (2001) Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163:152\u2013157","journal-title":"Am J Respir Crit Care Med"},{"key":"2148_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bcp.2012.11.021","volume":"85","author":"HE Tzeng","year":"2013","unstructured":"Tzeng HE, Tsai CH, Chang ZL, Su CM, Wang SW, Hwang WL et al (2013) Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma. Biochem Pharmacol 85:531\u2013540","journal-title":"Biochem Pharmacol"},{"key":"2148_CR79","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","volume":"61","author":"X Wu","year":"2024","unstructured":"Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M et al (2024) m(6)A-Mediated upregulation of LncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 Axis. Mol Neurobiol 61:5418\u20135440","journal-title":"Mol Neurobiol"},{"key":"2148_CR80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00432-024-05748-9","volume":"150","author":"W Shi","year":"2024","unstructured":"Shi W, Wang J, Chen J, Jin X, Wang Y, Yang L (2024) Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1\/JNK pathway. J Cancer Res Clin Oncol 150:218","journal-title":"J Cancer Res Clin Oncol"},{"key":"2148_CR81","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu R, Cai W, Jiang L, Chen K, Shi J et al (2025) Davunetide promotes structural and functional recovery of the injured spinal cord by promoting autophagy. Neural Regeneration Res","DOI":"10.4103\/NRR.NRR-D-24-00154"},{"key":"2148_CR82","doi-asserted-by":"publisher","first-page":"9757201","DOI":"10.1155\/2019\/9757201","volume":"2019","author":"W Fu","year":"2019","unstructured":"Fu W, Liu Y, Yin H (2019) Mitochondrial dynamics: biogenesis, fission, fusion, and mitophagy in the regulation of stem cell behaviors. Stem Cells Int 2019:9757201","journal-title":"Stem Cells Int"},{"key":"2148_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/156652406775574541","volume":"6","author":"Y Sekine","year":"2006","unstructured":"Sekine Y, Takeda K, Ichijo H (2006) The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases. Curr Mol Med 6:87\u201397","journal-title":"Curr Mol Med"},{"key":"2148_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jbior.2012.09.006","volume":"53","author":"S Shiizaki","year":"2013","unstructured":"Shiizaki S, Naguro I, Ichijo H (2013) Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling. Adv Biol Regul 53:135\u2013144","journal-title":"Adv Biol Regul"},{"key":"2148_CR85","doi-asserted-by":"publisher","first-page":"109436","DOI":"10.1016\/j.intimp.2022.109436","volume":"113","author":"L Wang","year":"2022","unstructured":"Wang L, Wang X, Deng L, Zhang H, He B, Cao W et al (2022) Pexidartinib (PLX3397) through restoring hippocampal synaptic plasticity ameliorates social isolation-induced mood disorders. Int Immunopharmacol 113:109436","journal-title":"Int Immunopharmacol"},{"key":"2148_CR86","doi-asserted-by":"publisher","first-page":"138026","DOI":"10.1016\/j.neulet.2024.138026","volume":"843","author":"AM Styla","year":"2024","unstructured":"Styla AM, Pitsikas N (2024) Joint administration of sub-threshold doses of the acetylcholinesterase inhibitor donepezil with those of the NMDA receptor antagonist ketamine improved rats\u2019 recognition memory abilities. Neurosci Lett 843:138026","journal-title":"Neurosci Lett"},{"key":"2148_CR87","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.62347\/YOPP4162","volume":"17","author":"H Wang","year":"2025","unstructured":"Wang H, Lv P (2025) Safety and efficacy of Rivastigmine and memantine combined for treatment of patients with alzheimer\u2019s disease: a retrospective study. Am J Translational Res 17:2240","journal-title":"Am J Translational Res"},{"key":"2148_CR88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al (2023) Lecanemab in early alzheimer\u2019s disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"2148_CR89","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J et al (2023) Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330:512\u2013527","journal-title":"JAMA"},{"key":"2148_CR90","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1379\/CSC-90R.1","volume":"10","author":"JR Hwang","year":"2005","unstructured":"Hwang JR, Zhang C, Patterson C (2005) C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell Stress Chaperones 10:147\u2013156","journal-title":"Cell Stress Chaperones"},{"key":"2148_CR91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1471-4159.2006.03730.x","volume":"97","author":"M Ouyang","year":"2006","unstructured":"Ouyang M, Shen X (2006) Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 97:234\u2013244","journal-title":"J Neurochem"},{"key":"2148_CR92","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1096\/fj.05-4376com","volume":"20","author":"CC Hsieh","year":"2006","unstructured":"Hsieh CC, Papaconstantinou J (2006) Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell Dwarf mice. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 20:259\u2013268","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"2148_CR93","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1128\/MCB.01369-06","volume":"27","author":"JM Lau","year":"2007","unstructured":"Lau JM, Jin X, Ren J, Avery J, DeBosch BJ, Treskov I et al (2007) The 14-3-3tau phosphoserine-binding protein is required for cardiomyocyte survival. Mol Cell Biol 27:1455\u20131466","journal-title":"Mol Cell Biol"},{"key":"2148_CR94","doi-asserted-by":"publisher","first-page":"17477","DOI":"10.1074\/jbc.273.28.17477","volume":"273","author":"Y Gotoh","year":"1998","unstructured":"Gotoh Y, Cooper JA (1998) Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J Biol Chem 273:17477\u201317482","journal-title":"J Biol Chem"},{"key":"2148_CR95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcp.10080","volume":"191","author":"K Tobiume","year":"2002","unstructured":"Tobiume K, Saitoh M, Ichijo H (2002) Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 191:95\u2013104","journal-title":"J Cell Physiol"},{"key":"2148_CR96","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1042\/BJ20070231","volume":"405","author":"J Saito","year":"2007","unstructured":"Saito J, Toriumi S, Awano K, Ichijo H, Sasaki K, Kobayashi T et al (2007) Regulation of apoptosis signal-regulating kinase 1 by protein phosphatase 2Cepsilon. Biochem J 405:591\u2013596","journal-title":"Biochem J"},{"key":"2148_CR97","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS (2020) Recent advancements in pathogenesis, diagnostics and treatment of alzheimer\u2019s disease. Curr Neuropharmacol 18:1106\u20131125","journal-title":"Curr Neuropharmacol"},{"key":"2148_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.semcdb.2020.04.002","volume":"105","author":"S Funamoto","year":"2020","unstructured":"Funamoto S, Tagami S, Okochi M, Morishima-Kawashima M (2020) Successive cleavage of \u03b2-amyloid precursor protein by \u03b3-secretase. Semin Cell Dev Biol 105:64\u201374","journal-title":"Semin Cell Dev Biol"},{"key":"2148_CR99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.cdd.4401528","volume":"12","author":"H Kadowaki","year":"2005","unstructured":"Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K et al (2005) Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 12:19\u201324","journal-title":"Cell Death Differ"},{"key":"2148_CR100","doi-asserted-by":"publisher","first-page":"20522","DOI":"10.1074\/jbc.M111.323279","volume":"287","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Varghese M, Ksiezak-Reding H, Dzhun A, Wang J, Pasinetti GM (2012) Paired helical filaments from alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. J Biol Chem 287:20522\u201320533","journal-title":"J Biol Chem"},{"key":"2148_CR101","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1523\/JNEUROSCI.21-19-07551.2001","volume":"21","author":"Y Morishima","year":"2001","unstructured":"Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R et al (2001) Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neuroscience: Official J Soc Neurosci 21:7551\u20137560","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"2148_CR102","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1046\/j.1471-4159.1999.0732609.x","volume":"73","author":"ME Kihiko","year":"1999","unstructured":"Kihiko ME, Tucker HM, Rydel RE, Estus S (1999) c-Jun contributes to amyloid beta-induced neuronal apoptosis but is not necessary for amyloid beta-induced c-jun induction. J Neurochem 73:2609\u20132612","journal-title":"J Neurochem"},{"key":"2148_CR103","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","volume":"74","author":"CH Reynolds","year":"2000","unstructured":"Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on Tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74:1587\u20131595","journal-title":"J Neurochem"},{"key":"2148_CR104","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1385\/NMM:5:3:205","volume":"5","author":"AL Peel","year":"2004","unstructured":"Peel AL, Sorscher N, Kim JY, Galvan V, Chen S, Bredesen DE (2004) Tau phosphorylation in alzheimer\u2019s disease: potential involvement of an APP-MAP kinase complex. Neuromol Med 5:205\u2013218","journal-title":"Neuromol Med"},{"key":"2148_CR105","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807\u2013869","journal-title":"Physiol Rev"},{"key":"2148_CR106","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1124\/jpet.103.051383","volume":"306","author":"Y Hashimoto","year":"2003","unstructured":"Hashimoto Y, Niikura T, Chiba T, Tsukamoto E, Kadowaki H, Nishitoh H et al (2003) The cytoplasmic domain of alzheimer\u2019s amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1\/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. J Pharmacol Exp Ther 306:889\u2013902","journal-title":"J Pharmacol Exp Ther"},{"key":"2148_CR107","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0006-291X(03)01283-X","volume":"307","author":"S Maruoka","year":"2003","unstructured":"Maruoka S, Hashimoto S, Gon Y, Nishitoh H, Takeshita I, Asai Y et al (2003) ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem Biophys Res Commun 307:870\u2013876","journal-title":"Biochem Biophys Res Commun"},{"key":"2148_CR108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nbd.2007.06.017","volume":"28","author":"V Galvan","year":"2007","unstructured":"Galvan V, Banwait S, Spilman P, Gorostiza OF, Peel A, Ataie M et al (2007) Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex. Neurobiol Dis 28:65\u201375","journal-title":"Neurobiol Dis"},{"key":"2148_CR109","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.cdd.4401818","volume":"13","author":"S Akterin","year":"2006","unstructured":"Akterin S, Cowburn RF, Miranda-Vizuete A, Jim\u00e9nez A, Bogdanovic N, Winblad B et al (2006) Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and alzheimer\u2019s disease. Cell Death Differ 13:1454\u20131465","journal-title":"Cell Death Differ"},{"key":"2148_CR110","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2022.05.023","volume":"518","author":"JS Jim\u00e9nez","year":"2023","unstructured":"Jim\u00e9nez JS (2023) Macromolecular structures and proteins interacting with the microtubule associated Tau protein. Neuroscience 518:70\u201382","journal-title":"Neuroscience"},{"key":"2148_CR111","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbr.2012.09.040","volume":"237","author":"M Cao","year":"2013","unstructured":"Cao M, Liu F, Ji F, Liang J, Liu L, Wu Q et al (2013) Effect of c-Jun N-terminal kinase (JNK)\/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced Tau protein hyperphosphorylation. Behav Brain Res 237:249\u2013255","journal-title":"Behav Brain Res"},{"key":"2148_CR112","doi-asserted-by":"publisher","first-page":"1145318","DOI":"10.3389\/fnins.2023.1145318","volume":"17","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang S, Meng Z, Ye Y, Shan G, Wang X et al (2023) Tau protein plays a role in the mechanism of cognitive disorders induced by anesthetic drugs. Front NeuroSci 17:1145318","journal-title":"Front NeuroSci"},{"key":"2148_CR113","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2990.2004.00569.x","volume":"30","author":"B Puig","year":"2004","unstructured":"Puig B, G\u00f3mez-Isla T, Rib\u00e9 E, Cuadrado M, Torrej\u00f3n-Escribano B, Dalf\u00f3 E et al (2004) Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK\/JNK-P) and p38 kinase (p38-P), and Tau hyperphosphorylation in neurites surrounding BetaA plaques in APP Tg2576 mice. Neuropathol Appl Neurobiol 30:491\u2013502","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2148_CR114","doi-asserted-by":"publisher","first-page":"155635","DOI":"10.1016\/j.phymed.2024.155635","volume":"129","author":"Z Lan","year":"2024","unstructured":"Lan Z, Tan F, He J, Liu J, Lu M, Hu Z et al (2024) Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia\/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization. Phytomedicine: Int J Phytotherapy Phytopharmacology 129:155635","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"2148_CR115","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12967-025-06298-5","volume":"23","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhao Z, Xie L, Xiao Z, Li M, Li Y et al (2025) Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma. J Translational Med 23:234","journal-title":"J Translational Med"},{"key":"2148_CR116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamaneurol.2021.4736","volume":"79","author":"R Gray","year":"2022","unstructured":"Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S et al (2022) Long-term effectiveness of adjuvant treatment with Catechol-O-Methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by Levodopa therapy: the PD MED randomized clinical trial. JAMA Neurol 79:131\u2013140","journal-title":"JAMA Neurol"},{"key":"2148_CR117","doi-asserted-by":"crossref","unstructured":"Bezard E, Gray D, Kozak R, Leoni M, Combs C, Duvvuri S (2024) Rationale and development of tavapadon, a D1\/D5-selective partial dopamine agonist for the treatment of parkinson\u2019s disease, vol 23. CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders, pp 476\u2013487","DOI":"10.2174\/1871527322666230331121028"},{"key":"2148_CR118","unstructured":"Rascol O, Ory-Magne F, Azulay J, Defebvre L, Houeto J, Maltete D et al (2023) Decreased occurrence of dyskinesia when combining amantadine to L-DOPA. Early Parkinson disease (PD): the PREMANDYSK trial. MOVEMENT DISORDERS: WILEY 111 RIVER ST, HOBOKEN 07030\u2013\u20095774. NJ USA, pp S46\u2013S"},{"key":"2148_CR119","doi-asserted-by":"crossref","unstructured":"Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL et al (2025) Psilocybin therapy for mood dysfunction in parkinson\u2019s disease: an open-label pilot trial. Neuropsychopharmacology","DOI":"10.2139\/ssrn.4871260"},{"key":"2148_CR120","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2023.2679","volume":"80","author":"RA Hauser","year":"2023","unstructured":"Hauser RA, Espay AJ, Ellenbogen AL, Fernandez HH, Isaacson SH, LeWitt PA et al (2023) IPX203 vs immediate-release carbidopa-levodopa for the treatment of motor fluctuations in Parkinson disease: the RISE-PD randomized clinical trial. JAMA Neurol 80:1062\u20131069","journal-title":"JAMA Neurol"},{"key":"2148_CR121","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neurobiolaging.2014.07.034","volume":"36","author":"KW Lee","year":"2015","unstructured":"Lee KW, Woo JM, Im JY, Park ES, He L, Ichijo H et al (2015) Apoptosis signal-regulating kinase 1 modulates the phenotype of \u03b1-synuclein Transgenic mice. Neurobiol Aging 36:519\u2013526","journal-title":"Neurobiol Aging"},{"key":"2148_CR122","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2019.09.012","volume":"85","author":"J Zhang","year":"2020","unstructured":"Zhang J, Park ES, Park HJ, Yan R, Grudniewska M, Zhang X et al (2020) Apoptosis signal regulating kinase 1 deletion mitigates \u03b1-synuclein pre-formed fibril propagation in mice. Neurobiol Aging 85:49\u201357","journal-title":"Neurobiol Aging"},{"key":"2148_CR123","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590","journal-title":"Lancet Neurol"},{"key":"2148_CR124","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.bbamcr.2017.09.001","volume":"1864","author":"JH Yoon","year":"2017","unstructured":"Yoon JH, Mo JS, Kim MY, Ann EJ, Ahn JS, Jo EH et al (2017) LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death. Biochim Et Biophys Acta Mol Cell Res 1864:2356\u20132368","journal-title":"Biochim Et Biophys Acta Mol Cell Res"},{"key":"2148_CR125","doi-asserted-by":"publisher","first-page":"9691","DOI":"10.1073\/pnas.0409635102","volume":"102","author":"E Junn","year":"2005","unstructured":"Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM (2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 102:9691\u20139696","journal-title":"Proc Natl Acad Sci USA"},{"key":"2148_CR126","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.abb.2011.07.016","volume":"515","author":"YL Niu","year":"2011","unstructured":"Niu YL, Li C, Zhang GY (2011) Blocking Daxx trafficking attenuates neuronal cell death following ischemia\/reperfusion in rat hippocampus CA1 region. Arch Biochem Biophys 515:89\u201398","journal-title":"Arch Biochem Biophys"},{"key":"2148_CR127","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S (2014) Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat 8:155","journal-title":"Front Neuroanat"},{"key":"2148_CR128","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nature13392","volume":"510","author":"F Koyano","year":"2014","unstructured":"Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M et al (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510:162\u2013166","journal-title":"Nature"},{"key":"2148_CR129","doi-asserted-by":"publisher","first-page":"e29935","DOI":"10.1371\/journal.pone.0029935","volume":"7","author":"KW Lee","year":"2012","unstructured":"Lee KW, Zhao X, Im JY, Grosso H, Jang WH, Chan TW et al (2012) Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation. PLoS ONE 7:e29935","journal-title":"PLoS ONE"},{"key":"2148_CR130","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1523\/JNEUROSCI.4589-10.2011","volume":"31","author":"X Hu","year":"2011","unstructured":"Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y et al (2011) Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via Attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neuroscience: Official J Soc Neurosci 31:247\u2013261","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"key":"2148_CR131","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1080\/10286020.2024.2371040","volume":"26","author":"Z Hui","year":"2024","unstructured":"Hui Z, Lai-Fa W, Xue-Qin W, Ling D, Bin-Sheng H, Li JM (2024) Mechanisms and therapeutic potential of Chinonin in nervous system diseases. J Asian Nat Prod Res 26:1405\u20131420","journal-title":"J Asian Nat Prod Res"},{"key":"2148_CR132","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamaneurol.2021.4893","volume":"79","author":"S Witzel","year":"2022","unstructured":"Witzel S, Maier A, Steinbach R, Grosskreutz J, Koch JC, Sarikidi A et al (2022) Safety and effectiveness of Long-term intravenous administration of Edaravone for treatment of patients with amyotrophic lateral sclerosis. JAMA Neurol 79:121\u2013130","journal-title":"JAMA Neurol"},{"key":"2148_CR133","doi-asserted-by":"publisher","first-page":"123290","DOI":"10.1016\/j.jns.2024.123290","volume":"467","author":"EP Pioro","year":"2024","unstructured":"Pioro EP, Brooks BR, Liu Y, Zhang J, Apple S (2024) Efficacy of Radicava\u00ae IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trial. J Neurol Sci 467:123290","journal-title":"J Neurol Sci"},{"key":"2148_CR134","doi-asserted-by":"publisher","first-page":"e0258614","DOI":"10.1371\/journal.pone.0258614","volume":"17","author":"BR Brooks","year":"2022","unstructured":"Brooks BR, Heiman-Patterson T, Wiedau-Pazos M, Liu S, Zhang J, Apple S (2022) Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of study 19 (MCI186-19)[clinical trial NCT01492686]. PLoS ONE 17:e0258614","journal-title":"PLoS ONE"},{"key":"2148_CR135","doi-asserted-by":"crossref","unstructured":"Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak \u00d6, Uzelac Z et al (2024) Effects of Tofersen treatment in patients with SOD1-ALS in a real-world setting\u2013a 12-month multicenter cohort study from the German early access program. EClinicalMedicine 69","DOI":"10.1016\/j.eclinm.2024.102495"},{"key":"2148_CR136","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/cns.70042","volume":"30","author":"PH Lin","year":"2024","unstructured":"Lin PH, Yao HY, Huang L, Fu CC, Yao XL, Lian C et al (2024) Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: retrospective research of clinical practice, biomarkers, and pathology. CNS Neurosci Ther 30:e70042","journal-title":"CNS Neurosci Ther"},{"key":"2148_CR137","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2217\/nmt-2021-0042","volume":"11","author":"B Oskarsson","year":"2021","unstructured":"Oskarsson B, Maragakis N, Bedlack RS, Goyal N, Meyer JA, Genge A et al (2021) MN-166 (ibudilast) in amyotrophic lateral sclerosis in a phase iib\/iii study: COMBAT-ALS study design. Neurodegenerative Disease Manage 11:431\u2013443","journal-title":"Neurodegenerative Disease Manage"},{"key":"2148_CR138","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jbior.2015.10.006","volume":"60","author":"Y Hayashi","year":"2016","unstructured":"Hayashi Y, Homma K, Ichijo H (2016) SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul 60:95\u2013104","journal-title":"Adv Biol Regul"},{"key":"2148_CR139","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainres.2005.03.037","volume":"1045","author":"SS Holasek","year":"2005","unstructured":"Holasek SS, Wengenack TM, Kandimalla KK, Montano C, Gregor DM, Curran GL et al (2005) Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in Transgenic mice. Brain Res 1045:185\u2013198","journal-title":"Brain Res"},{"key":"2148_CR140","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.mcn.2005.09.009","volume":"31","author":"P Veglianese","year":"2006","unstructured":"Veglianese P, Lo Coco D, Bao Cutrona M, Magnoni R, Pennacchini D, Pozzi B et al (2006) Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of Familial ALS. Mol Cell Neurosci 31:218\u2013231","journal-title":"Mol Cell Neurosci"},{"key":"2148_CR141","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainres.2004.08.054","volume":"1027","author":"TM Wengenack","year":"2004","unstructured":"Wengenack TM, Holasek SS, Montano CM, Gregor D, Curran GL, Poduslo JF (2004) Activation of programmed cell death markers in ventral Horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a Transgenic mouse model. Brain Res 1027:73\u201386","journal-title":"Brain Res"},{"key":"2148_CR142","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gad.1640108","volume":"22","author":"H Nishitoh","year":"2008","unstructured":"Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H et al (2008) ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 22:1451\u20131464","journal-title":"Genes Dev"},{"key":"2148_CR143","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/hmg\/ddv467","volume":"25","author":"T Fujisawa","year":"2016","unstructured":"Fujisawa T, Takahashi M, Tsukamoto Y, Yamaguchi N, Nakoji M, Endo M et al (2016) The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis. Hum Mol Genet 25:245\u2013253","journal-title":"Hum Mol Genet"},{"key":"2148_CR144","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.nbd.2006.12.023","volume":"26","author":"M Dewil","year":"2007","unstructured":"Dewil M, dela Cruz VF, Van Den Bosch L, Robberecht W (2007) Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis 26:332\u2013341","journal-title":"Neurobiol Dis"},{"key":"2148_CR145","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neulet.2018.09.040","volume":"687","author":"S Yokota","year":"2018","unstructured":"Yokota S, Kobatake Y, Noda Y, Nakata K, Yamato O, Hara H et al (2018) Activation of the unfolded protein response in canine degenerative myelopathy. Neurosci Lett 687:216\u2013222","journal-title":"Neurosci Lett"},{"key":"2148_CR146","first-page":"1","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR et al (2015) Huntington disease. Nat Reviews Disease Primers 1:1\u201321","journal-title":"Nat Reviews Disease Primers"},{"key":"2148_CR147","doi-asserted-by":"crossref","unstructured":"Berchtold D, Rennig J, Simillion C, Lipsmeier F, McColgan P, Lindemann M et al (2022) J03 evaluating Tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital Euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of Tominersen in adult individuals with manifest huntington\u2019s disease (HD). BMJ Publishing Group Ltd","DOI":"10.1136\/jnnp-2022-ehdn.253"},{"key":"2148_CR148","unstructured":"Hassan YRAI (2022) Investigations of Tominersen (RG6042) as a potential therapeutic for huntington\u2019s disease and studying the safety and tolerability of the lumbar puncture procedure in patients with huntington\u2019s disease. UCL (University College London)"},{"key":"2148_CR149","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s13023-023-02930-z","volume":"18","author":"R Csehi","year":"2023","unstructured":"Csehi R, Molnar V, Fedor M, Zsumbera V, Palasti A, Acsai K et al (2023) The improvement of motor symptoms in huntington\u2019s disease during Cariprazine treatment. Orphanet J Rare Dis 18:375","journal-title":"Orphanet J Rare Dis"},{"key":"2148_CR150","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.omtn.2022.04.031","volume":"28","author":"A Kotowska-Zimmer","year":"2022","unstructured":"Kotowska-Zimmer A, Przybyl L, Pewinska M, Suszynska-Zajczyk J, Wronka D, Figiel M et al (2022) A CAG repeat-targeting artificial MiRNA lowers the mutant Huntingtin level in the YAC128 model of huntington\u2019s disease. Mol Therapy Nucleic Acids 28:702\u2013715","journal-title":"Mol Therapy Nucleic Acids"},{"key":"2148_CR151","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.neuroscience.2009.07.048","volume":"163","author":"KJ Cho","year":"2009","unstructured":"Cho KJ, Lee BI, Cheon SY, Kim HW, Kim HJ, Kim GW (2009) Inhibition of apoptosis signal-regulating kinase 1 reduces Endoplasmic reticulum stress and nuclear Huntingtin fragments in a mouse model of huntington disease. Neuroscience 163:1128\u20131134","journal-title":"Neuroscience"},{"key":"2148_CR152","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","volume":"215","author":"V Perrin","year":"2009","unstructured":"Perrin V, Dufour N, Raoul C, Hassig R, Brouillet E, Aebischer P et al (2009) Implication of the JNK pathway in a rat model of huntington\u2019s disease. Exp Neurol 215:191\u2013200","journal-title":"Exp Neurol"},{"key":"2148_CR153","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2013.08.103","volume":"441","author":"KJ Cho","year":"2013","unstructured":"Cho KJ, Kim HW, Cheon SY, Lee JE, Kim GW (2013) Apoptosis signal-regulating kinase-1 aggravates ROS-mediated striatal degeneration in 3-nitropropionic acid-infused mice. Biochem Biophys Res Commun 441:280\u2013285","journal-title":"Biochem Biophys Res Commun"},{"key":"2148_CR154","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neulet.2007.10.042","volume":"430","author":"Y Minn","year":"2008","unstructured":"Minn Y, Cho KJ, Kim HW, Kim HJ, Suk SH, Lee BI et al (2008) Induction of apoptosis signal-regulating kinase 1 and oxidative stress mediate age-dependent vulnerability to 3-nitropropionic acid in the mouse striatum. Neurosci Lett 430:142\u2013146","journal-title":"Neurosci Lett"},{"key":"2148_CR155","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00109-007-0299-6","volume":"86","author":"L Arning","year":"2008","unstructured":"Arning L, Mont\u00e9 D, Hansen W, Wieczorek S, Jagiello P, Akkad DA et al (2008) ASK1 and MAP2K6 as modifiers of age at onset in huntington\u2019s disease. J Mol Med 86:485\u2013490","journal-title":"J Mol Med"},{"key":"2148_CR156","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2010.01.122","volume":"393","author":"J Ryu","year":"2010","unstructured":"Ryu J, Cho S, Park BC, Lee DH (2010) Oxidative stress-enhanced sumoylation and aggregation of ataxin-1: implication of JNK pathway. Biochem Biophys Res Commun 393:280\u2013285","journal-title":"Biochem Biophys Res Commun"},{"key":"2148_CR157","doi-asserted-by":"publisher","first-page":"175628642110076","DOI":"10.1177\/17562864211007687","volume":"14","author":"S Haase","year":"2021","unstructured":"Haase S, Linker RA (2021) Inflammation in multiple sclerosis. Ther Adv Neurol Disord 14:17562864211007687","journal-title":"Ther Adv Neurol Disord"},{"key":"2148_CR158","doi-asserted-by":"crossref","unstructured":"Khan Z, Mehan S, Gupta GD, Narula AS (2024) Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications. Neuroscience","DOI":"10.1016\/j.neuroscience.2024.04.004"},{"key":"2148_CR159","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00415-023-12113-2","volume":"271","author":"MY Abdelgaied","year":"2024","unstructured":"Abdelgaied MY, Rashad MH, El-Tayebi HM, Solayman MH (2024) The impact of Metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial. J Neurol 271:1124\u20131132","journal-title":"J Neurol"},{"key":"2148_CR160","doi-asserted-by":"publisher","first-page":"e2230439","DOI":"10.1001\/jamanetworkopen.2022.30439","volume":"5","author":"P Vermersch","year":"2022","unstructured":"Vermersch P, Scaramozza M, Levin S, Alroughani R, Deiva K, Pozzilli C et al (2022) Effect of dimethyl fumarate vs interferon \u03b2-1a in patients with Pediatric-Onset multiple sclerosis: the CONNECT randomized clinical trial. JAMA Netw Open 5:e2230439\u2013e","journal-title":"JAMA Netw Open"},{"key":"2148_CR161","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamaneurol.2020.2950","volume":"78","author":"BA Cree","year":"2021","unstructured":"Cree BA, Goldman MD, Corboy JR, Singer BA, Fox EJ, Arnold DL et al (2021) Efficacy and safety of 2 Fingolimod doses vs glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. JAMA Neurol 78:48\u201360","journal-title":"JAMA Neurol"},{"key":"2148_CR162","doi-asserted-by":"publisher","first-page":"1376494","DOI":"10.3389\/fphar.2024.1376494","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Yan Y, Liu S, Wang Z, Feng X (2024) Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database. Front Pharmacol 15:1376494","journal-title":"Front Pharmacol"},{"key":"2148_CR163","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/emmm.201000103","volume":"2","author":"X Guo","year":"2010","unstructured":"Guo X, Harada C, Namekata K, Matsuzawa A, Camps M, Ji H et al (2010) Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1\u2010p38 pathway. EMBO Mol Med 2:504\u2013515","journal-title":"EMBO Mol Med"},{"key":"2148_CR164","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00011-024-01913-5","volume":"73","author":"J Shen","year":"2024","unstructured":"Shen J, Lai W, Li Z, Zhu W, Bai X, Yang Z et al (2024) SDS3 regulates microglial inflammation by modulating the expression of the upstream kinase ASK1 in the p38 MAPK signaling pathway. Inflamm Res 73:1547\u20131564","journal-title":"Inflamm Res"},{"key":"2148_CR165","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2016.12.057","volume":"639","author":"Y Azuchi","year":"2017","unstructured":"Azuchi Y, Kimura A, Guo X, Akiyama G, Noro T, Harada C et al (2017) Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis. Neurosci Lett 639:82\u201387","journal-title":"Neurosci Lett"},{"key":"2148_CR166","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/0115672050364292250113063513","volume":"22","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Khan Y, Fatima R, Maqbool M, Ramalingam PS, Khan MG et al (2025) Microglial modulation in alzheimer\u2019s disease: central players in neuroinflammation and pathogenesis. Curr Alzheimer Res 22:56\u201382","journal-title":"Curr Alzheimer Res"},{"key":"2148_CR167","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan WW, Yang LT, Liu J, Dai ZY, Wang ZY, Zhang H et al (2024) A TGF-\u03b2 signaling-related LncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther 30:e14489","journal-title":"CNS Neurosci Ther"},{"key":"2148_CR168","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-018-0624-8","volume":"9","author":"KL Gibbs","year":"2018","unstructured":"Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P et al (2018) Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis 9:596","journal-title":"Cell Death Dis"},{"key":"2148_CR169","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1021\/tx200082h","volume":"24","author":"EA Liedhegner","year":"2011","unstructured":"Liedhegner EA, Steller KM, Mieyal JJ (2011) Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of parkinson\u2019s disease. Chem Res Toxicol 24:1644\u20131652","journal-title":"Chem Res Toxicol"},{"key":"2148_CR170","doi-asserted-by":"publisher","first-page":"111045","DOI":"10.1016\/j.brainresbull.2024.111045","volume":"216","author":"J Liao","year":"2024","unstructured":"Liao J, Duan Y, Liu Y, Chen H, An Z, Chen Y et al (2024) Simvastatin alleviates glymphatic system damage via the VEGF-C\/VEGFR3\/PI3K-Akt pathway after experimental intracerebral hemorrhage. Brain Res Bull 216:111045","journal-title":"Brain Res Bull"},{"key":"2148_CR171","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14728222.2020.1821648","volume":"24","author":"S Takenaka","year":"2020","unstructured":"Takenaka S, Fujisawa T, Ichijo H (2020) Apoptosis signal-regulating kinase 1 (ASK1) as a therapeutic target for neurological diseases. Expert Opin Ther Targets 24:1061\u20131064","journal-title":"Expert Opin Ther Targets"},{"key":"2148_CR172","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4155\/tde.10.95","volume":"2","author":"A Ulusoy","year":"2011","unstructured":"Ulusoy A, Kirik D (2011) Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for parkinson\u2019s disease. Therapeutic Delivery 2:37\u201350","journal-title":"Therapeutic Delivery"},{"key":"2148_CR173","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s40262-020-00878-y","volume":"59","author":"CH Nelson","year":"2020","unstructured":"Nelson CH, Etchevers K, Yi S, Breckenridge D, Hepner M, Patel U et al (2020) Pharmacokinetics, safety, and tolerability of selonsertib, an apoptosis Signal-Regulating kinase 1 (ASK1) inhibitor, following First-in-Human single and multiple ascending doses in healthy subjects. Clin Pharmacokinet 59:1109\u20131117","journal-title":"Clin Pharmacokinet"},{"key":"2148_CR174","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.29514","volume":"67","author":"R Loomba","year":"2018","unstructured":"Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H et al (2018) The ASK1 inhibitor Selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology (Baltimore MD) 67:549\u2013559","journal-title":"Hepatology (Baltimore MD)"},{"key":"2148_CR175","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"KA Gallo","year":"2002","unstructured":"Gallo KA, Johnson GL (2002) Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 3:663\u2013672","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2148_CR176","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10456-021-09787-5","volume":"24","author":"L Zhu","year":"2021","unstructured":"Zhu L, Lama S, Tu L, Dusting GJ, Wang JH, Liu GS (2021) TAK1 signaling is a potential therapeutic target for pathological angiogenesis. Angiogenesis 24:453\u2013470","journal-title":"Angiogenesis"},{"key":"2148_CR177","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1007\/s11064-022-03777-9","volume":"47","author":"JH Lee","year":"2022","unstructured":"Lee JH, Ji SH, Lim JS, Ahn S, Yun HY, Kim SH et al (2022) Anti-neuroinflammatory effects and brain Pharmacokinetic properties of selonsertib, an apoptosis signal-regulating kinase 1 inhibitor, in mice. Neurochem Res 47:3829\u20133837","journal-title":"Neurochem Res"},{"key":"2148_CR178","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pharmthera.2015.10.002","volume":"156","author":"P Wu","year":"2015","unstructured":"Wu P, Clausen MH, Nielsen TE (2015) Allosteric small-molecule kinase inhibitors. Pharmacol Ther 156:59\u201368","journal-title":"Pharmacol Ther"},{"key":"2148_CR179","doi-asserted-by":"crossref","unstructured":"Ranjan S, Dwivedi S, Singh S (2024) Synaptic plasticity and its uses. Synaptic plasticity in neurodegenerative disorders. CRC, pp 21\u201338","DOI":"10.1201\/9781003464648-3"},{"key":"2148_CR180","first-page":"251","volume-title":"Intellectual property rights in neuroprotective biomaterials","author":"C Prajapati","year":"2025","unstructured":"Prajapati C, Tripathi PN, Sood S, Rai SN, Mishra SS, Singh SK et al (2025) Intellectual property rights in neuroprotective biomaterials. Springer, Biomaterials and Neurodegenerative Disorders, pp 251\u2013269"},{"key":"2148_CR181","first-page":"69","volume-title":"Advanced biomaterials in neuroprotection: innovations and clinical applications","author":"K Ramakrishna","year":"2025","unstructured":"Ramakrishna K, Viswanadh MK, Dumala N, Chakravarth G, Venkateswarlu K, Gutti G et al (2025) Advanced biomaterials in neuroprotection: innovations and clinical applications. Springer, Biomaterials and Neurodegenerative Disorders, pp 69\u201392"},{"key":"2148_CR182","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jbior.2017.08.003","volume":"66","author":"X Guo","year":"2017","unstructured":"Guo X, Namekata K, Kimura A, Harada C, Harada T (2017) ASK1 in neurodegeneration. Adv Biol Regul 66:63\u201371","journal-title":"Adv Biol Regul"},{"key":"2148_CR183","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1080\/14728222.2020.1821648","volume":"24","author":"S Takenaka","year":"2020","unstructured":"Takenaka S, Takao F, Ichijo H (2020) Apoptosis signal-regulating kinase 1 (ASK1) as a therapeutic target for neurological diseases. Expert Opin Ther Targets 24:1061\u20131064","journal-title":"Expert Opin Ther Targets"},{"key":"2148_CR184","doi-asserted-by":"publisher","first-page":"127405","DOI":"10.1016\/j.bmcl.2020.127405","volume":"30","author":"SV Bigi-Botterill","year":"2020","unstructured":"Bigi-Botterill SV, Ivetac A, Bradshaw EL, Cole D, Dougan DR, Ermolieff J et al (2020) Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile. Bioorg Med Chem Lett 30:127405","journal-title":"Bioorg Med Chem Lett"},{"key":"2148_CR185","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-023-02923-6","volume":"20","author":"S Meng","year":"2023","unstructured":"Meng S, Cao H, Huang Y, Shi Z, Li J, Wang Y et al (2023) ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood\u2013brain barrier integrity after traumatic brain injury. J Neuroinflamm 20:244","journal-title":"J Neuroinflamm"},{"key":"2148_CR186","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00109-018-01739-9","volume":"97","author":"SY Cheon","year":"2019","unstructured":"Cheon SY, Cho KJ (2019) Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders. J Mol Med 97:153\u2013161","journal-title":"J Mol Med"},{"key":"2148_CR187","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1568009623666230817102104","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Z, Tang Z, Fu Y, Wang L (2024) mirna-383-5p functions as an Anti-oncogene in glioma through the akt\/mtor signaling pathway by targeting VEGFA. Curr Cancer Drug Targets 24:463\u2013475","journal-title":"Curr Cancer Drug Targets"},{"key":"2148_CR188","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JAD-170645","volume":"61","author":"Y Hasegawa","year":"2018","unstructured":"Hasegawa Y, Toyama K, Uekawa K, Ichijo H, Kim-Mitsuyama S (2018) Role of ASK1\/p38 cascade in a mouse model of alzheimer\u2019s disease and brain aging. J Alzheimer\u2019s Disease 61:259\u2013263","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2148_CR189","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3233\/JAD-215687","volume":"90","author":"W-B Shen","year":"2022","unstructured":"Shen W-B, Elahi M, Wang B, Zhan M, Yang P, Yang P (2022) Oxidative stress kinase activation and impaired insulin receptor signaling precede overt alzheimer\u2019s disease neuropathology. J Alzheimer\u2019s Disease 90:841\u2013857","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2148_CR190","doi-asserted-by":"crossref","unstructured":"Zhao F, Li C, Zhuang Y, Yan Y, Gao Y, Behnisch T (2024) Apoptosis signal-regulating kinase 1 (Ask1) deficiency alleviates MPP+-induced impairment of evoked dopamine release in the mouse hippocampus. Front Cell Neurosci. 18","DOI":"10.3389\/fncel.2024.1288991"},{"key":"2148_CR191","first-page":"2356","volume":"1864","author":"J-H Yoon","year":"2017","unstructured":"Yoon J-H, Mo J-S, Kim M-Y, Ann E-J, Ahn J-S, Jo E-H et al (2017) LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death. Biochimica et biophysica acta (BBA). Mol Cell Res 1864:2356\u20132368","journal-title":"Mol Cell Res"},{"key":"2148_CR192","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1096\/fj.06-7580com","volume":"21","author":"S Karunakaran","year":"2007","unstructured":"Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S et al (2007) Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, daxx, in substantia Nigra Pars compacta in a mouse model of parkinson\u2019s disease: protection by alpha-lipoic acid. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 21:2226\u20132236","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"2148_CR193","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2015.06.041","volume":"87","author":"A Ray","year":"2015","unstructured":"Ray A, Sehgal N, Karunakaran S, Rangarajan G, Ravindranath V (2015) MPTP activates ASK1\u2013p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. Free Radic Biol Med 87:312\u2013325","journal-title":"Free Radic Biol Med"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02148-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02148-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:03:23Z","timestamp":1758917003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02148-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":193,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02148-3","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"7 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}